Dmitri V. Krysko

21.3k total citations · 10 hit papers
124 papers, 15.1k citations indexed

About

Dmitri V. Krysko is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dmitri V. Krysko has authored 124 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Immunology, 54 papers in Molecular Biology and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dmitri V. Krysko's work include Phagocytosis and Immune Regulation (28 papers), Nanoplatforms for cancer theranostics (24 papers) and Cell death mechanisms and regulation (18 papers). Dmitri V. Krysko is often cited by papers focused on Phagocytosis and Immune Regulation (28 papers), Nanoplatforms for cancer theranostics (24 papers) and Cell death mechanisms and regulation (18 papers). Dmitri V. Krysko collaborates with scholars based in Belgium, Russia and Germany. Dmitri V. Krysko's co-authors include Peter Vandenabeele, Agnieszka Kaczmarek, Abhishek D. Garg, Patrizia Agostinis, Olga Krysko, Katharina D’Herde, Marcus Conrad, José Pedro Friedmann Angeli, Claus Bachert and Tom Vanden Berghe and has published in prestigious journals such as Nature Communications, Nature reviews. Cancer and The EMBO Journal.

In The Last Decade

Dmitri V. Krysko

121 papers receiving 14.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunogenic cell death and DAMPs in cancer therapy

2012 2.5k citations Dmitri V. Krysko, Olga Krysko et al. profile →
Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance

2013 1.1k citations Peter Vandenabeele, Dmitri V. Krysko et al. profile →
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion

2019 965 citations Dmitri V. Krysko et al. profile →
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

2012 651 citations Dmitri V. Krysko, Peter Vandenabeele et al. profile →
Apoptosis and necrosis: Detection, discrimination and phagocytosis

2008 540 citations Dmitri V. Krysko, Peter Vandenabeele et al. profile →
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation

2011 539 citations Dmitri V. Krysko, Olga Krysko et al. profile →
Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future

2021 439 citations Tatiana A. Mishchenko, Maria V. Vedunova et al. Journal for ImmunoTherapy of Cancer profile →
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity

2020 367 citations Iuliia Efimova, Elena Catanzaro et al. Journal for ImmunoTherapy of Cancer profile →
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity

2016 364 citations Tinneke Delvaeye, Luc Leybaert et al. profile →
Which cell death modality wins the contest for photodynamic therapy of cancer?

2022 185 citations Tatiana A. Mishchenko, Maria V. Vedunova et al. profile →

Peers

Countries citing papers authored by Dmitri V. Krysko

Since Specialization

Citations

This map shows the geographic impact of Dmitri V. Krysko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitri V. Krysko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitri V. Krysko more than expected).

Fields of papers citing papers by Dmitri V. Krysko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitri V. Krysko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitri V. Krysko. The network helps show where Dmitri V. Krysko may publish in the future.

Co-authorship network of co-authors of Dmitri V. Krysko

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitri V. Krysko. A scholar is included among the top collaborators of Dmitri V. Krysko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitri V. Krysko. Dmitri V. Krysko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Palmitoylation regulates ferroptosis and anti-tumor immunity 2025 ·Nature Cancer ·(unknown), (unknown), Dmitri V. Krysko	0
2	A Ferrocene-Based Supramolecular Photothermal Agent for Enhanced Photothermal/Ferroptosis Therapy and Immune Activation 2025 ·Biomacromolecules ·Jing Qian, Dongmei Jiang, (unknown), Dmitri V. Krysko, Jia Tian, Weian Zhang	0
3	CX3CL1: a key switch of cell death immunogenicity 2025 ·Trends in cancer ·(unknown), (unknown), Dmitri V. Krysko	0
4	Cytofluorometric analysis of the maturation and activation of bone marrow-derived dendritic cells to assess immunogenic cell death 2024 ·Methods in cell biology ·(unknown), Iuliia Efimova, (unknown), Dmitri V. Krysko	2
5	CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Iuliia Efimova, (unknown), Greet De Smet, Tatiana A. Mishchenko, Maria V. Vedunova, Olga Krysko, Elena Catanzaro, Dmitri V. Krysko	6
6	Enhancing glioma treatment with 3D scaffolds laden with upconversion nanoparticles and temozolomide in orthotopic mouse model 2024 ·Frontiers in Chemistry ·Tatiana A. Mishchenko, (unknown), Evgenii L. Guryev, Alexander G. Savelyev, Dmitri V. Krysko, Sergey V. Gudkov, E. V. Khaydukov, Andrei V. Zvyagin, Maria V. Vedunova	1
7	Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool 2024 ·Journal of Controlled Release ·(unknown), Dmitri V. Krysko, (unknown), Karine Breckpot, Michel Versluis, Stefaan C. De Smedt, Guillaume Lajoinie, Ine Lentacker	5
8	The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments 2023 ·Journal of Controlled Release ·(unknown), (unknown), Iuliia Efimova, Dmitri V. Krysko, Lynn De Backer, Stefaan C. De Smedt, Koen Raemdonck	3
9	Immunogenic ferroptosis protects against the development of tumour growth 2023 ·Genes and Cells ·(unknown), Victoria D. Turubanova, (unknown), Tatiana A. Mishchenko, Maria V. Vedunova, Dmitri V. Krysko	1
10	Mechanobiology of Ferroptotic Cancer Cells as a Novel “Eat‐Me” Signal: Regulating Efferocytosis through Layer‐by‐Layer Coating 2023 ·Advanced Healthcare Materials ·Louis Van der Meeren, Iuliia Efimova, (unknown), Bogdan V. Parakhonskiy, Dmitri V. Krysko, André G. Skirtach	7
11	High‐throughput mechano‐cytometry as a method to detect apoptosis, necroptosis, and ferroptosis 2023 ·Cell Proliferation ·Louis Van der Meeren, (unknown), Dmitri V. Krysko, André G. Skirtach	8
12	Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery 2020 ·Molecules ·Francesca Seghetti, Rita Maria Concetta Di Martino, Elena Catanzaro, Alessandra Bisi, Silvia Gobbi, Angela Rampa, Barbara Canonico, (unknown), Dmitri V. Krysko, Stefano Papa, Carmela Fimognari, Federica Belluti	20
13	Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity breakdown → 2020 ·Journal for ImmunoTherapy of Cancer ·Iuliia Efimova, Elena Catanzaro, Louis Van der Meeren, Victoria D. Turubanova, Hamida Hammad, Tatiana A. Mishchenko, Maria V. Vedunova, Carmela Fimognari, Claus Bachert, Frauke Coppieters, Steve Lefever, André G. Skirtach, Olga Krysko, Dmitri V. Krysko	367
14	Blocking connexin43 hemichannels protects mice against tumour necrosis factor-induced inflammatory shock 2019 ·Scientific Reports ·Tinneke Delvaeye, Maarten De Smet, (unknown), Elke Decrock, (unknown), Roosmarijn E. Vandenbroucke, Kelly Lemeire, Amanda Gonçalves, Wim Declercq, Peter Vandenabeele, Dmitri V. Krysko, Luc Leybaert	22
15	Protease/antiprotease network in allergy: The role of Staphylococcus aureus protease‐like proteins 2019 ·Allergy ·Olga Krysko, Andrea Teufelberger, (unknown), Dmitri V. Krysko, Claus Bachert	37
16	Staphylococcus aureus Orchestrates Type 2 Airway Diseases 2019 ·Trends in Molecular Medicine ·Andrea Teufelberger, Barbara M. Bröker, Dmitri V. Krysko, Claus Bachert, Olga Krysko	52
17	Necroptosis: A Novel Cell Death Modality and Its Potential Relevance for Critical Care Medicine 2016 ·American Journal of Respiratory and Critical Care Medicine ·Gabriel Moreno‐González, Peter Vandenabeele, Dmitri V. Krysko	72
18	The adjuvant‐like activity of staphylococcal enterotoxin B in a murine asthma model is independent of IL‐1R signaling 2013 ·Allergy ·Olga Krysko, Tania Maes, Maud Plantinga, Gabriële Holtappels, (unknown), Peter Vandenabeele, Guy Joos, Dmitri V. Krysko, Claus Bachert	14
19	Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis 2010 ·Allergy ·Olga Krysko, Gabriële Holtappels, Nan Zhang, Małgorzata Kubica, Kim Deswarte, Lara Derycke, Sofie Claeys, Hamida Hammad, Guy Brusselle, Peter Vandenabeele, Dmitri V. Krysko, C. Bachert	141
20	Cell death: initiation, propagation and clearance 2006 ·Ghent University Academic Bibliography (Ghent University) ·Dmitri V. Krysko	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact